Burden of Disease Predicts Response to Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma

Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program

(2014) Paolo Antonio Ascierto et al.   CANCER INVESTIGATION

Isolated Limb Infusion in a Series of Over 100 Infusions: A Single-Center Experience

(2013) Joyce Wong et al.   ANNALS OF SURGICAL ONCOLOGY

CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients

(2013) P. A. Ott et al.   CLINICAL CANCER RESEARCH

Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion

(2013) Jonathan Steinman et al.   JOURNAL OF SURGICAL ONCOLOGY

Predicting Disease Progression After Regional Therapy for In-Transit Melanoma

(2013) Michael E. Lidsky et al.   JAMA Surgery

A Multicenter Prospective Evaluation of the Clinical Utility of F-18 FDG-PET/CT in Patients With AJCC Stage IIIB or IIIC Extremity Melanoma

(2012) Georgia M. Beasley et al.   ANNALS OF SURGERY

A Multi-institutional Experience of Repeat Regional Chemotherapy for Recurrent Melanoma of Extremities

(2011) Christy Y. Chai et al.   ANNALS OF SURGICAL ONCOLOGY

Current Trends in Regional Therapy for Melanoma: Lessons Learned from 225 Regional Chemotherapy Treatments between 1995 and 2010 at a Single Institution

(2011) Amanda K. Raymond et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Predictive Factors of Regional Toxicity and Serum Creatine Phosphokinase Levels After Isolated Limb Infusion for Melanoma: A Multi-Institutional Analysis

(2009) Alfredo A. Santillan et al.   ANNALS OF SURGICAL ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US

(2009) Georgia M. Beasley et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial

(2009) Mary S. Brady et al.   MELANOMA RESEARCH

Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience

(2008) Hidde M. Kroon et al.   ANNALS OF SURGICAL ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER